Stuttgart - Delayed Quote EUR
Glass House Brands Inc (4KF0.SG)
4.2200
+0.1000
+(2.43%)
As of 5:06:53 PM GMT+2. Market Open.
Loading Chart for 4KF0.SG
- Previous Close
4.1200 - Open
4.0200 - Bid 4.2400 x --
- Ask 4.7200 x --
- Day's Range
4.0200 - 4.2200 - 52 Week Range
1.8700 - 9.2500 - Volume
0 - Avg. Volume
95 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 4KF0.SG
View MorePerformance Overview: 4KF0.SG
Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
4KF0.SG
15.60%
MSCI WORLD (^990100-USD-STRD)
4.26%
1-Year Return
4KF0.SG
45.55%
MSCI WORLD (^990100-USD-STRD)
6.84%
3-Year Return
4KF0.SG
46.24%
MSCI WORLD (^990100-USD-STRD)
23.15%
5-Year Return
4KF0.SG
46.24%
MSCI WORLD (^990100-USD-STRD)
79.80%
Compare To: 4KF0.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
4.2200
+2.43%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4049
+4.25%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4101
+4.94%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4024
+2.13%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4165
+4.26%
Mkt Cap EUR 415.199M
Industry Drug Manufacturers—Specialty & Generic
0.4283
+2.76%
Mkt Cap EUR 426.962M
Industry Drug Manufacturers—Specialty & Generic
0.6300
-1.56%
Mkt Cap CAD 628.032M
Industry Drug Manufacturers—Specialty & Generic
0.4515
-1.40%
Mkt Cap 450.09M
Industry Drug Manufacturers—Specialty & Generic
Statistics: 4KF0.SG
View MoreValuation Measures
As of 4/22/2025
Market Cap
331.74M
Enterprise Value
362.39M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.78
Price/Book (mrq)
3.15
Enterprise Value/Revenue
2.08
Enterprise Value/EBITDA
11.77
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--